Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors

MLA

Efstathios K. Iliodromitis, et al. “Investigating and Re-Evaluating the Role of Glycogen Synthase Kinase 3 Beta Kinase as a Molecular Target for Cardioprotection by Using Novel Pharmacological Inhibitors.” Cardiovascular Research, vol. 115, Mar. 2019, pp. 1228–43. EBSCOhost, https://doi.org/10.1093/cvr/cvz061.

APA

Efstathios K. Iliodromitis, Alexios-Leandros Skaltsounis, Ioanna Andreadou, Panagiota-Efstathia Nikolaou, Andreas Papapetropoulos, Kerstin Boengler, Vassilios Myrianthopoulos, Anna Tsantili-Kakoulidou, Nicholas Gaboriaud-Kolar, Nikolaos Kostomitsopoulos, Rainer Schulz, Konstantina Vouvogiannopoulou, Pavlos Alexakos, Ioannis Rerras, Panagiotis Efentakis, & Anastasia Zoga. (2019). Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors. Cardiovascular Research, 115, 1228–1243. https://doi.org/10.1093/cvr/cvz061

Chicago

Efstathios K. Iliodromitis, Alexios-Leandros Skaltsounis, Ioanna Andreadou, Panagiota-Efstathia Nikolaou, Andreas Papapetropoulos, Kerstin Boengler, Vassilios Myrianthopoulos, et al. 2019. “Investigating and Re-Evaluating the Role of Glycogen Synthase Kinase 3 Beta Kinase as a Molecular Target for Cardioprotection by Using Novel Pharmacological Inhibitors.” Cardiovascular Research 115 (March): 1228–43. doi:10.1093/cvr/cvz061.